{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:39:06Z","timestamp":1790422746589,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vascular calcification (VC) is well described in large- and medium-sized vessels in patients with chronic kidney disease (CKD), especially in those with end-stage kidney disease (ESKD) on dialysis. Medial calcification is particularly prevalent in this population and contributes to arterial stiffness and increased cardiovascular mortality and morbidity. Apart from in the setting of calciphylaxis, few studies have assessed skin and subcutaneous calcification and associations with abnormalities of bone and mineral metabolism in patients with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a single-centre observational study to evaluate incisional skin tissue samples from three anatomical sites in patients with different stages of CKD undergoing elective surgery. We compared these samples to skin samples of a control cohort without CKD. Staining for calcification was performed with von Kossa method. A subgroup of skin samples were assessed by RT-PCR for upregulation of pro-calcific gene transcripts for tissue non-specific alkaline phosphatase (\n                      <jats:italic>TNAP)<\/jats:italic>\n                      and Runt-related transcription factor 2 (\n                      <jats:italic>RUNX2<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty-five patients were evaluated, 34 with CKD (including ESKD) and 11 control patients. VC was identified in 15 skin samples (13 CKD\/ESKD and 2 controls). VC was present in the dermal and subcutaneous tissues of the neck, abdomen and arm samples. Two different histological types of VC were identified: speckled medial calcification and internal elastic lamina calcification. Presence of perieccrine calcification was identified in 14 samples, 10 with concurrent VC. There were no significant differences in serum parathyroid hormone, phosphate or calcium in patients with or without VC. Expression of\n                      <jats:italic>TNAP<\/jats:italic>\n                      or\n                      <jats:italic>RUNX2<\/jats:italic>\n                      was not increased in samples from patients with ESKD or those with histological evidence of calcification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reports the novel finding of dermal and subcutaneous calcification in multiple anatomical locations in 38% of patients with advanced CKD\/ESKD undergoing elective surgery but free from calciphylaxis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01928-0","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T05:02:46Z","timestamp":1594875766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Irene","family":"Ruderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim D.","family":"Hewitson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Wigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel D.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"issue":"5","key":"1928_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/sdi.12710","volume":"31","author":"I Ruderman","year":"2018","unstructured":"Ruderman I, Holt SG, Hewitson TD, et al. Current and potential therapeutic strategies for the management of vascular calcification in patients with chronic kidney disease including those on dialysis. Semin Dial. 2018;31(5):487\u201399.","journal-title":"Semin Dial"},{"issue":"6","key":"1928_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.ackd.2019.07.001","volume":"26","author":"ER Smith","year":"2019","unstructured":"Smith ER, Hewitson TD, Holt SG. Diagnostic tests for vascular calcification. Adv Chronic Kidney Dis. 2019;26(6):445\u201363.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"20","key":"1928_CR3","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478\u201383.","journal-title":"N Engl J Med"},{"key":"1928_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18:1731\u201340.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1928_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938\u201342.","journal-title":"Hypertension"},{"issue":"3","key":"1928_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ki.2013.351","volume":"85","author":"WC O'Neill","year":"2014","unstructured":"O'Neill WC, Adams AL. Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation. Kidney Int. 2014;85(3):668\u201376.","journal-title":"Kidney Int"},{"issue":"2","key":"1928_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.kint.2018.03.016","volume":"94","author":"CL Ellis","year":"2018","unstructured":"Ellis CL, O'Neill WC. Questionable specificity of histologic findings in calcific uremic arteriolopathy. Kidney Int. 2018;94(2):390\u20135.","journal-title":"Kidney Int"},{"issue":"5","key":"1928_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/DAD.0b013e31827c7f5d","volume":"35","author":"MC Mochel","year":"2013","unstructured":"Mochel MC, Arakaki RY, Wang G, et al. Cutaneous calciphylaxis: a retrospective histopathologic evaluation. Am J Dermatopathol. 2013;35(5):582\u20136.","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"1928_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1309\/AGLF-X21H-Y37W-50KL","volume":"113","author":"LR Essary","year":"2000","unstructured":"Essary LR, Wick MR. Cutaneous calciphylaxis. An underrecognized clinicopathologic entity. Am J Clin Pathol. 2000;113(2):280\u20137.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"1928_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jaad.2006.08.065","volume":"56","author":"RH Weenig","year":"2007","unstructured":"Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569\u201379.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"1928_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00467-013-2746-7","volume":"29","author":"VM Brandenburg","year":"2014","unstructured":"Brandenburg VM, Sinha S, Specht P, et al. Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder. Pediatr Nephrol. 2014;29(12):2289\u201398.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1928_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/MNH.0000000000000328","volume":"26","author":"SU Nigwekar","year":"2017","unstructured":"Nigwekar SU. Calciphylaxis. Curr Opin Nephrol Hypertens. 2017;26(4):276\u201381.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1928_CR13","volume-title":"Histopathology of the skin: general principles","author":"R Cerio","year":"2010","unstructured":"Cerio R, Calonje E. Histopathology of the skin: general principles. Oxford: Wiley-Blackwell; 2010."},{"key":"1928_CR14","unstructured":"Vinay Kumar RSCSLR, with illustrations by James AP. Robbins basic pathology. Seventh edition. Philadelphia, PA : Saunders, [2003] \u00a92003, Placed Published: 2003."},{"issue":"4","key":"1928_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/ndt\/gfs466","volume":"28","author":"R Kramann","year":"2013","unstructured":"Kramann R, Brandenburg VM, Schurgers LJ, et al. Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy. Nephrol Dial Transplant. 2013;28(4):856\u201368.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1928_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","volume":"178","author":"A Pai","year":"2011","unstructured":"Pai A, Leaf EM, El-Abbadi M, et al. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol. 2011;178(2):764\u201373.","journal-title":"Am J Pathol"},{"issue":"21","key":"1928_CR17","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","volume":"100","author":"CM Shanahan","year":"1999","unstructured":"Shanahan CM, Cary NR, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Monckeberg\u2019s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100(21):2168\u201376.","journal-title":"Circulation"},{"issue":"1","key":"1928_CR18","first-page":"9","volume":"4","author":"C Dookhan","year":"2015","unstructured":"Dookhan C, Ortega LM, Nayer A, et al. Perieccrine and pericapillary calcification in calciphylaxis. J Ren Inj Prev. 2015;4(1):9\u201310.","journal-title":"J Ren Inj Prev"},{"issue":"1","key":"1928_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2215\/CJN.01760506","volume":"2","author":"ML Gross","year":"2007","unstructured":"Gross ML, Meyer HP, Ziebart H, et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol. 2007;2(1):121\u201334.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1928_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1681\/ASN.2009080829","volume":"21","author":"G Schlieper","year":"2010","unstructured":"Schlieper G, Aretz A, Verberckmoes SC, et al. Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol. 2010;21(4):689\u201396.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1928_CR21","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.ajpath.2015.03.020","volume":"185","author":"ME Lin","year":"2015","unstructured":"Lin ME, Chen T, Leaf EM, et al. Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol. 2015;185(7):1958\u201369.","journal-title":"Am J Pathol"},{"issue":"18","key":"1928_CR22","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.18632\/aging.102297","volume":"11","author":"J Donate-Correa","year":"2019","unstructured":"Donate-Correa J, Mart\u00edn-N\u00fa\u00f1ez E, Hern\u00e1ndez-Carballo C, et al. Fibroblast growth factor 23 expression in human calcified vascular tissues. Aging. 2019;11(18):7899\u2013913.","journal-title":"Aging"},{"key":"1928_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-4939-3353-2_13","volume":"1397","author":"ER Smith","year":"2016","unstructured":"Smith ER. Vascular calcification in uremia: new-age concepts about an old-age problem. Methods Mol Biol. 2016;1397:175\u2013208.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"1928_CR24","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.kint.2017.06.019","volume":"92","author":"L Hortells","year":"2017","unstructured":"Hortells L, Sosa C, Guillen N, et al. Identifying early pathogenic events during vascular calcification in uremic rats. Kidney Int. 2017;92(6):1384\u201394.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01928-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01928-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T19:32:32Z","timestamp":1626377552000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01928-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1928"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01928-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"30 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research performed in accordance with the Declaration of Helsinki. The study was approved by the Melbourne Health Human Research Ethics Committee (#HREC 2017.023). Written informed consent was obtained for all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to current manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ERS has received research funding from Sanofi, Baxter, and Amgen and holds stock in Calciscon AG, which specializes in performing the T<sub>50<\/sub>-test.SGH has received research funding, teaching and travel support from Astra-Zenica, Amgen, Baxter, Sanofi.NDT has received honoraria, travel support and research funding from Amgen, Shire and Sanofi. TDH, BW and IR declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}